Evaluation of The Association Between Obesity, Dietary Phytochemical Index, and Breast Cancer Risk and Knowledge Level

Main Article Content

Gözde Çalışkan https://orcid.org/0000-0001-8026-3422
Bartu Eren Güneşliol https://orcid.org/0000-0002-0472-7835
Neslihan Sürmeli Akçadağ https://orcid.org/0000-0001-6476-7209
Nilüfer Acar Tek https://orcid.org/0000-0002-8772-9608


Dietary phytochemical index, breast cancer, obesity


Abstract. Breast cancer is one of the most common cancers globally and has been reported as the leading cause of cancer-related death in women. Obesity is defined as one of the most important risk factors for breast cancer. Besides, oncological studies have reported that regular daily consumption of phytochemicals can reduce the risk of breast cancer. Therefore, this study aimed to clarify the association between obesity, dietary phytochemical index (DPI), breast cancer risk (BCR) and knowledge level (BCKL). Methods: This study was conducted with women aged 18 years and older. Participants filled out sociodemographic and lifestyle characteristics, anthropometric data, 24-hour retrospective food consumption records, BCR, and BCKL scales via Google forms. Body weight, height, and waist circumference (WC) were declared by the participants. BMI, waist to height ratio (WtHr), DPI, BCR and BCKL calculations were made by the researchers. Results: In terms of BCR, 94.2% of the participants were in the low, 3.3% in the medium, 0.3% in the high, and 2.2% in the highest risk group. Besides, there were significant differences between body weight, height, BMI, WC, and WtHr values of BCR groups. Yet, no significant difference was observed between the DPI of BCR groups. Moreover, DPI was not associated with BMI, WC, BCR, and BCKL. However, BMI was significantly correlated (moderate-to-strong) with WC and BCR (r=0.719 and r=0.605, respectively). Also, WC was significantly correlated (moderate) with BCR (r=0.475). The association between WC and BCKL (r=0.088) was statistically significant but not clinically. Conclusion: In conclusion, although BCR was not associated with DPI, it was associated with BMI and WC values, which are the indicators of obesity. In the light of this information, the associations between obesity, DPI, BCR, and BCKL will be understood more clearly in future studies with a large sample in which BCR groups have an equal distribution.

Abstract 292 | PDF Downloads 369


1. Cardoso F, Costa A, Norton L, et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). The Breast 2012;21:242-52.
2. Aslan FE, Gürkan A. Kadinlarda meme kanseri risk düzeyi. J Breast Health 2007; 3: 63-8.
3. Peto R, Davies C, Godwin J, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. The Lancet 2012; 379: 432-44.
4. Karayurt Ö, Zorukoş SN. Meme Kanseri Riski Yüksek Olan Kadinlarin Yaşadiklari Duygular ve Bilgi-Destek Gereksinimlerinin Karşilanmasi. J Breast Health 2008; 4: 56-61.
5. Tümer A, Baybek H. Çalışan kadınlarda meme kanseri risk düzeyi. J Breast Health 2010; 6: 17-21.
6. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006; 296: 193-201.
7. McKenzie F, Ferrari P, Freisling H, Chajès V, Rinaldi S, De Batlle J, et al. Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study. Int J Cancer 2015; 136: 2640-8.
8. Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA oncology. 2015; 1: 611-21.
9. Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat Res 1995; 339: 73-89.
10. Moulder S, Hortobagyi G. Advances in the treatment of breast cancer. Clin Pharmacol Ther 2008; 83: 26-36.
11. Isakoff SJ. Triple negative breast cancer: role of specific chemotherapy agents. Cancer J 2010; 16: 53.
12. Cazzaniga M, Bonanni B. Breast cancer chemoprevention: old and new approaches. J Biomed Biotechnol 2012; 2012: 985620.
13. Tan AC, Konczak I, Sze DM-Y, Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr Cancer 2011; 63: 495-505.
14. Waladkhani A, Clemens MR. Effect of dietary phytochemicals on cancer development. Int J Mol Med 1998; 1: 747-800.
15. Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: fruits. J Agric Food Chem 2001; 49: 5315-21.
16. Casagrande F, Darbon J-M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 2001; 61: 1205-15.
17. Vijayababu M, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas M, Arunakaran J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 2005; 131: 765-71.
18. Tan KW, Li Y, Paxton JW, Birch NP, Scheepens A. Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food chem 2013; 138: 2267-74.
19. Chen P, Li C, Li X, Li J, Chu R, Wang H. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. Br J Cancer 2014; 110: 2327-38.
20. Crew KD, Brown P, Greenlee H, et al. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon e in women with hormone receptor–negative breast cancer. Cancer Prev Res 2012; 5: 1144-54.
21. Toledo E, Salas-Salvadó J, Donat-Vargas C, et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med 2015; 175: 1752-60.
22. Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. Epigenetic activation of BRCA1 by genistein in vivo and triple negative breast cancer cells linked to antagonism toward Aryl hydrocarbon receptor. Nutrients 2019; 11: 2559.
23. Dastpeyman M, Motamed N, Azadmanesh K, et al. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI. Med Oncol 2012; 29: 2512-8.
24. Mock CD, Jordan BC, Selvam C. Recent advances of curcumin and its analogues in breast cancer prevention and treatment. RSC Adv 2015; 5: 75575-88.
25. Surh Y-J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-80.
26. Weir CB, Jan A. BMI Classification Percentile And Cut Off Points. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541070/
27. McCarty MF. Proposal for a dietary “phytochemical index”. Med Hypotheses 2004; 63: 813-7.
28. T.C. Sağlık Bakanlığı, Ana Çocuk Sağlığı ve Aile Planlaması Genel Müdürlüğü. Ulusal Aile Planlaması Hizmet Rehberi, Cilt II Aile Planlaması ve Üreme Sağlığı. Ankara: 2005. Available from: https://mersinism.saglik.gov.tr/Eklenti/11202/0/97836rehber-cilt-2pdf.pdf
29. Spence W. Health EDCO. A Division of WRS Group. Inc, Waco, Texas. 2000.
30. Stager JL. The comprehensive breast cancer knowledge test: validity and reliability. J Adv Nurs 1993; 18: 1133-40.
31. Başak SÇ. Breast Cancer Knowledge Level In University Students: Reliability and Validity of Comprehensive Breast Cancer Knowledge Test. Master Thesis, Okan University, Social Sciences Institute, Department of Psychology, Istanbul, Turkey, 2015 (Director: Dr. Ahmet Tosun). Available from: https://tez.yok.gov.tr/UlusalTezMerkezi/tezSorguSonucYeni.jsp (accessed on July 10, 2021).
32. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30.
33. Ito N, Hasegawa R, Sano M, et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP). Carcinogenesis 1991; 12: 1503-6.
34. Onat H, Başaran M. Meme kanseri risk faktörleri ve korunma. Meme Kanseri. Editörler: Topuz E, Aydıner A, Dinçer M. Nobel Matbaacılık, İstanbul, 2003; 1: 90-107.
35. Centers for Disease Control and Prevention. What are the risk factors? Available from: https://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm
36. Eroglu C, Eryilmaz MA, Civcik S, Gurbuz Z. Breast Cancer Risk Assessment: 5000 Cases. International Journal of Hematology & Oncology 2010; 20: 27-33.
37. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-38.
38. Van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152: 514-27.
39. Gaudet MM, Carter BD, Patel AV, Teras LR, Jacobs EJ, Gapstur SM. Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. Cancer Causes Control. 2014; 25: 737-45.
40. Kabat GC, Kim MY, Lee JS, et al. Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2017; 26: 1730-5.
41. Bodur S, Eryılmaz MA, Civcik S, Durduran Y. Kanserlerin toplumdaki dağılımının belirlenmesi ve insidansın tahmininde KETEM kayıtlarının katkısı: Konya örneği. Genel Tip Dergisi. 2011; 21: 144-51.
42. Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, Kolonel LN. Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. Breast Cancer Res Treat 2011; 129: 565-74.
43. Lu Y, Ma H, Malone KE, et al. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol 2011; 29: 3358-65.
44. De Waard F, Baanders-van Halewijn EA. A prospective study in general practice on breast-cancer risk in postmenopausal women. Int J Cancer 1974; 14: 153-60.
45. Castello A, Pollán M, Buijsse B, et al. Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study. Br J Cancer 2014; 111: 1454-62.
46. Bahadoran Z, Karimi Z, Houshiar-Rad A, Mirzayi H-R, Rashidkhani B. Dietary phytochemical index and the risk of breast cancer: a case control study in a population of Iranian women. Asian Pac J Cancer Prev 2013; 14: 2747-51.
47. Warren BS, Devine C. Meat, Poultry and Fish and the Risk of Breast Cancer. Cornell University Program on Breast Cancer and Environmental Risk Factors in New York State (BCERF), 2000, Fact Sheet 39.